| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 21 | 2024 | 754 | 9.210 |
Why?
|
| Embolization, Therapeutic | 16 | 2024 | 262 | 8.840 |
Why?
|
| Carcinoma, Hepatocellular | 16 | 2024 | 390 | 8.420 |
Why?
|
| Vena Cava Filters | 14 | 2022 | 97 | 7.890 |
Why?
|
| Radiography, Interventional | 14 | 2024 | 154 | 4.940 |
Why?
|
| Vena Cava, Inferior | 8 | 2022 | 145 | 4.320 |
Why?
|
| Bile Duct Neoplasms | 6 | 2024 | 90 | 4.220 |
Why?
|
| Venous Thrombosis | 9 | 2022 | 250 | 3.940 |
Why?
|
| Yttrium Radioisotopes | 13 | 2024 | 58 | 3.870 |
Why?
|
| Device Removal | 9 | 2022 | 167 | 3.750 |
Why?
|
| Cholangiocarcinoma | 5 | 2024 | 76 | 3.530 |
Why?
|
| Pulmonary Embolism | 6 | 2024 | 228 | 3.130 |
Why?
|
| Radiology, Interventional | 7 | 2022 | 69 | 3.110 |
Why?
|
| Angiography | 9 | 2024 | 208 | 2.720 |
Why?
|
| Treatment Outcome | 36 | 2024 | 8203 | 2.500 |
Why?
|
| Foreign-Body Migration | 4 | 2020 | 39 | 2.480 |
Why?
|
| Chemoembolization, Therapeutic | 4 | 2023 | 35 | 2.450 |
Why?
|
| Prosthesis Implantation | 4 | 2020 | 126 | 2.340 |
Why?
|
| Medicare | 6 | 2023 | 423 | 2.340 |
Why?
|
| Catheter Ablation | 4 | 2022 | 252 | 2.170 |
Why?
|
| Computed Tomography Angiography | 7 | 2022 | 146 | 1.990 |
Why?
|
| Radiopharmaceuticals | 4 | 2024 | 193 | 1.680 |
Why?
|
| Thrombectomy | 7 | 2023 | 172 | 1.670 |
Why?
|
| Thrombolytic Therapy | 4 | 2023 | 232 | 1.640 |
Why?
|
| Osteoarthritis, Knee | 2 | 2024 | 66 | 1.620 |
Why?
|
| Humans | 76 | 2024 | 89063 | 1.500 |
Why?
|
| Retrospective Studies | 27 | 2024 | 9003 | 1.460 |
Why?
|
| Microspheres | 7 | 2024 | 108 | 1.370 |
Why?
|
| Endovascular Procedures | 3 | 2024 | 270 | 1.350 |
Why?
|
| Brachytherapy | 2 | 2021 | 121 | 1.300 |
Why?
|
| Venous Thromboembolism | 2 | 2021 | 159 | 1.280 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2018 | 599 | 1.230 |
Why?
|
| Gastrostomy | 2 | 2021 | 69 | 1.230 |
Why?
|
| Malpractice | 2 | 2019 | 57 | 1.220 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 116 | 1.170 |
Why?
|
| Social Media | 2 | 2020 | 93 | 1.160 |
Why?
|
| Radiology | 2 | 2020 | 199 | 1.130 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2024 | 43 | 1.100 |
Why?
|
| Bile Ducts, Intrahepatic | 5 | 2023 | 72 | 1.070 |
Why?
|
| Catheterization | 3 | 2021 | 237 | 1.050 |
Why?
|
| Lower Extremity | 2 | 2023 | 87 | 1.050 |
Why?
|
| Liability, Legal | 3 | 2022 | 32 | 1.020 |
Why?
|
| Radiation Dosage | 3 | 2020 | 225 | 1.010 |
Why?
|
| Consensus | 2 | 2024 | 356 | 0.970 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2024 | 63 | 0.940 |
Why?
|
| Hepatic Artery | 2 | 2024 | 84 | 0.940 |
Why?
|
| Recurrence | 2 | 2024 | 1140 | 0.890 |
Why?
|
| Diagnostic Imaging | 2 | 2019 | 479 | 0.880 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2024 | 237 | 0.880 |
Why?
|
| Hepatic Encephalopathy | 1 | 2023 | 39 | 0.860 |
Why?
|
| Liver Abscess | 1 | 2022 | 12 | 0.860 |
Why?
|
| Hepatectomy | 1 | 2024 | 170 | 0.850 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2024 | 2657 | 0.840 |
Why?
|
| Ischemia | 1 | 2024 | 251 | 0.810 |
Why?
|
| Fistula | 1 | 2021 | 42 | 0.750 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 34 | 0.740 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2021 | 53 | 0.730 |
Why?
|
| Hospital Units | 1 | 2020 | 30 | 0.730 |
Why?
|
| Tumor Burden | 4 | 2024 | 308 | 0.730 |
Why?
|
| Aged | 19 | 2024 | 19077 | 0.730 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.720 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.710 |
Why?
|
| Surgical Instruments | 1 | 2020 | 57 | 0.700 |
Why?
|
| Vascular Diseases | 1 | 2021 | 118 | 0.700 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 78 | 0.700 |
Why?
|
| Hydrocephalus | 1 | 2021 | 104 | 0.700 |
Why?
|
| Catheters | 3 | 2022 | 76 | 0.690 |
Why?
|
| Societies, Medical | 2 | 2021 | 570 | 0.690 |
Why?
|
| Wounds, Gunshot | 1 | 2021 | 90 | 0.680 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2017 | 71 | 0.670 |
Why?
|
| Middle Aged | 22 | 2024 | 25863 | 0.670 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 114 | 0.660 |
Why?
|
| Radiologists | 1 | 2019 | 46 | 0.660 |
Why?
|
| Kyphoplasty | 1 | 2019 | 7 | 0.660 |
Why?
|
| United States | 10 | 2024 | 6955 | 0.650 |
Why?
|
| Thrombosis | 1 | 2022 | 302 | 0.650 |
Why?
|
| Fractures, Compression | 1 | 2019 | 17 | 0.650 |
Why?
|
| Aorta | 1 | 2020 | 288 | 0.640 |
Why?
|
| Specialization | 1 | 2019 | 65 | 0.630 |
Why?
|
| Appendicitis | 1 | 2019 | 64 | 0.630 |
Why?
|
| Stents | 1 | 2021 | 395 | 0.620 |
Why?
|
| Aged, 80 and over | 11 | 2021 | 6777 | 0.620 |
Why?
|
| Spinal Fractures | 1 | 2019 | 77 | 0.610 |
Why?
|
| Rectum | 1 | 2019 | 148 | 0.610 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2018 | 103 | 0.600 |
Why?
|
| Radiation Injuries | 1 | 2019 | 160 | 0.600 |
Why?
|
| Risk Factors | 12 | 2024 | 5466 | 0.600 |
Why?
|
| Hemorrhage | 1 | 2019 | 278 | 0.590 |
Why?
|
| Renal Dialysis | 2 | 2017 | 335 | 0.580 |
Why?
|
| Time Factors | 8 | 2024 | 5320 | 0.580 |
Why?
|
| Prosthesis Design | 4 | 2019 | 296 | 0.580 |
Why?
|
| Radiosurgery | 1 | 2020 | 280 | 0.580 |
Why?
|
| Acute Disease | 3 | 2024 | 841 | 0.570 |
Why?
|
| Catheters, Indwelling | 2 | 2014 | 113 | 0.560 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 358 | 0.560 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 205 | 0.540 |
Why?
|
| Physicians | 2 | 2022 | 689 | 0.530 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1063 | 0.530 |
Why?
|
| Female | 24 | 2024 | 46011 | 0.530 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2019 | 295 | 0.520 |
Why?
|
| Finger Phalanges | 1 | 2015 | 4 | 0.520 |
Why?
|
| Male | 21 | 2024 | 42251 | 0.520 |
Why?
|
| Metacarpal Bones | 1 | 2015 | 12 | 0.510 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 5 | 0.480 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2014 | 99 | 0.470 |
Why?
|
| Sutures | 1 | 2014 | 53 | 0.470 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 53 | 0.460 |
Why?
|
| Phlebography | 3 | 2018 | 66 | 0.440 |
Why?
|
| Salvage Therapy | 1 | 2014 | 235 | 0.440 |
Why?
|
| Suture Techniques | 1 | 2014 | 140 | 0.440 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 329 | 0.420 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2024 | 36 | 0.420 |
Why?
|
| Microwaves | 2 | 2022 | 36 | 0.410 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 849 | 0.410 |
Why?
|
| Heart Ventricles | 1 | 2017 | 779 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 1096 | 0.400 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 1194 | 0.390 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 217 | 0.370 |
Why?
|
| Adult | 11 | 2024 | 26507 | 0.350 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2022 | 168 | 0.350 |
Why?
|
| Adolescent | 7 | 2021 | 9237 | 0.350 |
Why?
|
| Vascular Patency | 2 | 2022 | 126 | 0.350 |
Why?
|
| Young Adult | 6 | 2021 | 6288 | 0.340 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2023 | 99 | 0.340 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2019 | 38 | 0.320 |
Why?
|
| Anticoagulants | 2 | 2021 | 426 | 0.300 |
Why?
|
| Fluoroscopy | 3 | 2024 | 122 | 0.290 |
Why?
|
| United States Food and Drug Administration | 2 | 2017 | 133 | 0.280 |
Why?
|
| Pneumothorax | 2 | 2015 | 53 | 0.240 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 70 | 0.240 |
Why?
|
| Transfusion Medicine | 1 | 2024 | 4 | 0.240 |
Why?
|
| Hypertrophy | 1 | 2024 | 67 | 0.230 |
Why?
|
| Liver Regeneration | 1 | 2024 | 36 | 0.230 |
Why?
|
| Biopsy | 2 | 2020 | 1182 | 0.230 |
Why?
|
| Radiometry | 1 | 2024 | 56 | 0.230 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 123 | 0.230 |
Why?
|
| Equipment Design | 2 | 2015 | 415 | 0.220 |
Why?
|
| Lasers, Excimer | 1 | 2022 | 5 | 0.220 |
Why?
|
| Fractures, Spontaneous | 1 | 2023 | 11 | 0.220 |
Why?
|
| Necrosis | 1 | 2023 | 209 | 0.220 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 214 | 0.210 |
Why?
|
| Arteries | 1 | 2023 | 180 | 0.210 |
Why?
|
| Capecitabine | 1 | 2022 | 98 | 0.210 |
Why?
|
| Hypertension, Portal | 1 | 2022 | 46 | 0.210 |
Why?
|
| Perfusion | 1 | 2023 | 235 | 0.210 |
Why?
|
| Biomarkers | 2 | 2021 | 1755 | 0.200 |
Why?
|
| Transplants | 1 | 2022 | 41 | 0.200 |
Why?
|
| Iliac Vein | 1 | 2022 | 30 | 0.200 |
Why?
|
| Aneurysm | 1 | 2022 | 60 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2024 | 168 | 0.200 |
Why?
|
| Contraindications, Procedure | 1 | 2021 | 7 | 0.200 |
Why?
|
| Contraindications, Drug | 1 | 2021 | 4 | 0.200 |
Why?
|
| Sheep | 1 | 2022 | 250 | 0.200 |
Why?
|
| Fibrinolysis | 1 | 2022 | 37 | 0.200 |
Why?
|
| Postoperative Complications | 3 | 2017 | 2275 | 0.190 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 254 | 0.190 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 56 | 0.190 |
Why?
|
| Orthopedic Procedures | 1 | 2023 | 129 | 0.190 |
Why?
|
| Orthopedics | 1 | 2023 | 125 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 102 | 0.190 |
Why?
|
| Retreatment | 1 | 2021 | 108 | 0.190 |
Why?
|
| Pain | 1 | 2023 | 400 | 0.190 |
Why?
|
| Liver Function Tests | 1 | 2020 | 92 | 0.180 |
Why?
|
| Postoperative Hemorrhage | 1 | 2021 | 46 | 0.180 |
Why?
|
| Cisplatin | 1 | 2022 | 617 | 0.180 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 98 | 0.180 |
Why?
|
| Mechanical Thrombolysis | 1 | 2020 | 16 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.180 |
Why?
|
| Research Design | 1 | 2024 | 597 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 80 | 0.180 |
Why?
|
| Hypotension | 1 | 2020 | 71 | 0.170 |
Why?
|
| Radiation Exposure | 1 | 2019 | 24 | 0.170 |
Why?
|
| Congresses as Topic | 1 | 2020 | 112 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.170 |
Why?
|
| Disease Progression | 1 | 2024 | 1488 | 0.170 |
Why?
|
| Organs at Risk | 1 | 2019 | 40 | 0.160 |
Why?
|
| Mortality | 1 | 2020 | 149 | 0.160 |
Why?
|
| Appendectomy | 1 | 2019 | 36 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2021 | 711 | 0.160 |
Why?
|
| Radiography | 2 | 2019 | 809 | 0.160 |
Why?
|
| Anesthesia, General | 1 | 2019 | 118 | 0.160 |
Why?
|
| Glass | 1 | 2018 | 15 | 0.160 |
Why?
|
| Nephrectomy | 1 | 2021 | 293 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 60 | 0.160 |
Why?
|
| Patient Care Team | 1 | 2021 | 283 | 0.160 |
Why?
|
| Hydrogels | 1 | 2019 | 86 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 136 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 257 | 0.160 |
Why?
|
| Contrast Media | 2 | 2024 | 1090 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1706 | 0.160 |
Why?
|
| Bone Marrow | 1 | 2020 | 445 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 433 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 266 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 833 | 0.150 |
Why?
|
| Jurisprudence | 1 | 2017 | 25 | 0.150 |
Why?
|
| Equipment Safety | 1 | 2017 | 33 | 0.150 |
Why?
|
| Chicago | 2 | 2019 | 1423 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 319 | 0.140 |
Why?
|
| Liver | 2 | 2024 | 1205 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 948 | 0.140 |
Why?
|
| Coronary Angiography | 1 | 2017 | 242 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 779 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1715 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 3657 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 442 | 0.130 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.130 |
Why?
|
| Hemodynamics | 1 | 2019 | 729 | 0.130 |
Why?
|
| Chest Tubes | 1 | 2015 | 24 | 0.130 |
Why?
|
| Kidney | 1 | 2021 | 1145 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 635 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 2001 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2017 | 346 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 859 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2022 | 1177 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 233 | 0.120 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 23 | 0.120 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 1837 | 0.120 |
Why?
|
| Thorax | 1 | 2014 | 77 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2021 | 3717 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 115 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 360 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 2552 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 2290 | 0.110 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 16 | 0.110 |
Why?
|
| Mesentery | 1 | 2013 | 45 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2014 | 184 | 0.110 |
Why?
|
| Choristoma | 1 | 2013 | 68 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 86 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 988 | 0.100 |
Why?
|
| Pancreas | 1 | 2013 | 244 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1591 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1043 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 756 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 233 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2024 | 34 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 142 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 321 | 0.060 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2024 | 43 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2024 | 166 | 0.050 |
Why?
|
| Splenic Artery | 1 | 2022 | 11 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 155 | 0.050 |
Why?
|
| Animals | 1 | 2022 | 27317 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 147 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2347 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2022 | 150 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 149 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 192 | 0.050 |
Why?
|
| Incidence | 2 | 2015 | 1592 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2022 | 254 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2022 | 235 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2022 | 996 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1012 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 275 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2022 | 1214 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 848 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1212 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1855 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2863 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 4273 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 157 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3443 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 1889 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2014 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 948 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1867 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2752 | 0.020 |
Why?
|
| Lung | 1 | 2014 | 1258 | 0.020 |
Why?
|